Europe PMCopen access
Phase 1/2 randomized, observer-blind clinical trial of a first-generation, mRNA-based vaccine against seasonal influenza and COVID-19 in healthy adults
Messenger RNA, Influenza, Randomized Clinical Trial, Multicomponent Vaccine, Phase 1/2, Sars-cov-2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 5148
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.